Coxsackieviruses B (CVB) (B1-B6), positive-strand RNA viruses, cause a variety of diseases. CVB4 may have a causal role in insulin-dependent diabetes mellitus. IFN-␣ inhibits CVB replication; however, the mechanism is not well known. The interferon-␣-inducible human MxA protein exerts an antiviral activity against negative-strand RNA viruses and against Semliki Forest virus, a positive-strand RNA virus. To test the antiviral spectrum of MxA against CVB4, we took advantage of stably transfected Vero cells expressing MxA (Vero/MxA) in 98% of cells. Compared with control cells, in Vero/MxA cells, CVB4 yields were dramatically reduced and expression of the VP1 CVB protein analyzed by immunofluorescence was highly restricted. Furthermore, the accumulation of positive-and negative-strand CVB4 RNA was prevented as shown by in situ hybridization and RT-PCR. These results indicate that the antiviral activity of MxA extends to CVB4 and that its replication cycle is inhibited at an early step in Vero/MxA cells.
INTRODUCTION
Coxsackieviruses B1-B6 (CVB), members of the enterovirus group in the Picornaviridae family, are nonenveloped viruses. Their genome is a single positive-strand RNA, contained in a capsid composed of 60 protomers, each consisting of one copy of the viral proteins VP1, VP2, VP3, and VP4. The viruses enter the cell via cellular receptors (Bergelson et al., 1997; De Verdugo et al., 1995; Shafren et al., 1995) . The mechanism of uncoating is not well known; into the cell, viral RNA associates with ribosomes. The viral genome serves as mRNA for the synthesis of a polyprotein precursor cleaved to yield the viral proteins. The positive-strand RNA is copied into negative strands which in turn serve as templates for the synthesis of positive-strand genomic RNAs or are translated in proteins. Structural proteins such as VP1, formed by cleavage of the precursor polyprotein, associate with positive-strand RNA to form virions that free themselves from the cells by cell lysis (Rueckert et al., 1996) .
Coxsackieviruses B are highly prevalent human pathogens associated with a variety of acute diseases (myocarditis, meningoencephalitis, Bornholm disease, herpangina, etc.) (Melnick, 1996) . Studies indicate that CVB3 and CVB4 may have a causal role in chronic diseases such as chronic myocarditis and insulin-dependent type 1 diabetes (Kandolf et al., 1993; Graves et al., 1997) . Increased levels of IFN-␣ in plasma have been associated with CVB infection, and IFN-␣ mRNA has been detected in the blood cells of individuals with EV RNA in their blood (Chehadeh et al., 2000a; Dommergues et al., 1994) . IFN-␣ is known to play an important role in primary defense against viral infections. Following treatment with IFN-␣, CVB infection is impaired in mice (Matsumori et al., 1988) and IFN-␣ can inhibit CVB replication in cultured cells (Heim et al., 1995 (Heim et al., , 1997 .
IFN-␣ and -␤ exert pleiotropic effects on cells by interaction with a cell-surface receptor. Then, the IFN-␣ antiviral activity is mediated, in part, by inducing intracellular proteins, such as 2Ј-5Ј oligoadenylate synthetase (2Ј-5Ј OAS), a 68-kDa protein kinase (PKR), or MxA protein (for review, see Taylor and Grossberg, 1990) . Human MxA, a 78-kDa protein induced specifically by IFN-␣ and IFN-␤ but not by other cytokines, accumulates in the cytoplasm (Horisberger and Hochkepel, 1987; Simon et al., 1991) . The MxA is a GTPase, and the loss of GTP binding due to mutations in the GTP-binding element of MxA is accompanied by a loss of antiviral activity (Ponten et al., 1997; Pitossi et al., 1993) .
MxA protein inhibits the multiplication of negativestrand RNA viruses such as influenza virus, vesicular stomatitus virus (VSV), measles virus, or other viruses belonging to the family Bunyaviridae (Pavlovic et al., 1990 (Pavlovic et al., , 1992 Schneider-Schaulies et al., 1994; Schnorr et al., 1993; Frese et al., 1995 Frese et al., , 1996 . Moreover, it has been reported that MxA-transfected cells were protected against Semliki Forest virus (SFV), a togavirus with a single-stranded RNA genome of positive polarity, whereas they were not protected against the multiplication of other positive-stranded RNA virus, mengovirus, and encephalomyocarditis virus belonging to the Picornaviridae family and against the multiplication of a DNA virus, herpes simplex virus type 1 (Pavlovic et al., 1990; Landis et al., 1998) .
It has been reported that 2Ј-5Ј OAS-transfected Chinese hamster ovary (CHO) cell clones are resistant to the infection by picornavirus such as mengovirus (Chebath et al., 1987) . Mengovirus and EMCV are murine viruses, members of the cardioviruses, one out of the six genera that make up the Picornaviridae family. The mechanisms of the antiviral activity of IFN-␣ against CVB belonging to an other genera of this family has not been studied. In response to IFN, a variety of IFN-inducible proteins with different antiviral activities are produced, but the antiviral protein(s) interfering with CVB replication is(are) not known. The present study demonstrates in vitro that the multiplication of CVB4, a positive-strand RNA virus, is inhibited in MxA expressing cells.
RESULTS

Inhibition of CVB4 replication in MxA-transfected cells
MxA-transfected Vero cells (VA9) and pSV2-transfected Vero cells (VN5) were tested for MxA expression by indirect immunofluorescence and the MxA protein was quantitated by using a method based on immunochemiluminescence. MxA accumulated in the cytoplasm of VA9 cells and showed a granular staining pattern (Fig. 1A) . MxA was expressed in more than 98% of the cells as judged by immunofluorescence analysis. No MxA staining was evidenced in VN5 cells. An enhanced MxA level was detected in VA9 cells compared with VN5 cells. The MxA level in VN5 did not differ from background values obtained in various cell lines ( Fig. 1B) .
VA9, VN5, and HEp-2 cells were incubated in the presence of CVB4 or VSV, both at m.o.i. 0.1 for 2 h 30 min. Then unadsorbed viruses were removed by washing and the cultures were continued. CVB-induced cytopathic effects in VA9 and VN5 cells were assessed by microscopic examination at various time points and culture supernatants from CVB4, and VSV-infected cells, harvested at 24-h postinfection, were subjected to virus-yield reduction assays in HEp-2 cells. There was no cytopathic effect of CVB4 in VA9 cells up to 72-h postinfection, whereas 25 and 100% of the monolayers were altered at 24-and 72-h postinfection in VN5 cells ( Fig. 2A) . No CPE was observed in HEp-2 cells when they were cultured in the presence of supernatant samples obtained from CVB4-or VSVexposed VA9 cells; the virus titers in supernatants from these cultures were Ͻ1 ϫ 10 1 TCID50/ml. Oppositely, 2 ϫ 10 4 and 3 ϫ 10 5 TCID50/ml were detected in supernatant samples of CVB4-and VSV-infected VN5 cell cultures, respectively (Fig. 2B) . In contrast, the replication of HSV-1 was not affected by MxA; indeed, the HSV-1-induced cytopathic effect was not different in VA9 and VN5 cells. More than 25% of cells were destroyed 24-h postinfection in both cases (data not shown). The protein 2Ј-5Ј OAS is one of the functionally important type I IFN-induced intracellular proteins which plays a major role in defense against virus infection, including picornavirus (Chebath et al., 1987) . Therefore the levels of 2Ј-5Ј OAS-induced 2Ј-5Ј adenylate in CVB4-infected VA9 and VN5 cells has been evaluated. Figure 3 shows that the 2Ј-5Ј adenylate levels were higher in VA9 and VN5 cells treated with IFN-␣ for 12 h compared with controls, whereas CVB4 infection did not increase the 2Ј-5Ј adenylate levels in these cells. Decreased synthesis of capsid protein and viral RNA in MxA-transfected cells infected with CVB VA9, VN5, and HEp-2 cells were incubated in the presence of CVB4 at m.o.i. 0.1 for 2 h 30 min. Then, unadsorbed virus was removed by washing and the cultures were continued for 24 and 48 h. The presence of the enterovirus structural protein VP1 (VP1) was studied by using an indirect immunofluorescent assay (see Fig.  4 ). VP1 was not detected in cells 4-h postinfection, whereas a positive signal appeared at 7-h postinfection in cytoplasm of VN5 and HEp-2 cells, but not in the one of VA9 cells. The proportion of VP-1-positive cells reached 50% 24 h.p.i. for both VN5 and HEp-2 cells. Oppositely, no VA9 cell was positive for VP1 at 24 h.p.i. At 48 h.p.i., more than 80% of CVB4-infected VN5 and HEp-2 cells accumulated VP1 in their cytoplasm, whereas no VA9 was positive for FITC staining of VP1 at this time. Mock-infected VN5, VA9, and HEp2 cells were negative for indirect immunofluorescent assay. At each studied time postinfection, the viability of VA9 cells was more than 90% as tested by Trypan blue exclusion assay (data not shown).
To determine whether the synthesis of CVB4 RNA occurred in MxA-expressing cells, monolayers of transfected Vero, control, and HEp-2 cells were exposed to CVB4 at a m.o.i. of 1; then, accumulation of viral RNA was monitored 4 and 24 h.p.i. by in situ hybridization (ISH) (see Fig. 5 ). At 4 h.p.i., 15% of CVB4-infected VN5 cells were positive, whereas no VA9 cell was revealed CVB4 RNA positive. At 24 h.p.i., 40-50% of CVB4-infected VN5 cells were viral RNA positive, whereas no CVB4 RNA accumulation was observed in VA9 cells.
To further explore the CVB4 replication, the cells were washed extensively at 4°C to remove residual viruses, then plus-and minus-sense viral RNA strands were studied by RT-PCR (see Fig. 6 ). At 4 h.p.i., the detection of plus-sense viral RNA strands was positive in VN5 and HEp-2 cells and weakly positive in VA9 cells, whereas the detection of minus-sense viral RNA strands was positive in HEp-2 cells only (data not shown). At 24 h.p.i, significant accumulation of positive-and negative-strand viral RNA occurred in infected HEp-2 and VN5 cells, whereas the signal for the detection of positive-strand viral RNA was weak in VA9 cells and that the signal for the detection of negative-strand viral RNA was absent in these cells.
DISCUSSION
The antiviral activity of Mx proteins has been reported against negative-and positive-strand RNA viruses (Frese et al., 1995 (Frese et al., , 1996 Staeheli and Pavlovic, 1991; Schwemmle et al., 1995) , whereas it has been reported that MxA had no effect on Mengo virus or ECM virus belonging to the Picornaviridae family (Landis et al., 1998) . In the present study, the antiviral spectrum of MxA against CVB4, a member of the enterovirus group in the Picornaviridae family, has been investigated.
FIG. 3. Quantitation of 2Ј-5Ј adenylate generated in MxA-expressing Vero cells (VA9) and control cells (VN5). Infected were 0.5 ϫ 10 5 cells with CVB4 (m.o.i. 0.1 for 2 h 30 min at 37°C; then the unadsorbed virus was removed by washing and the cultures were continued); mockinfected; or treated with 100 IU/ml IFN-␣ 2b . The cells were cultured for 12 h; then they were washed and the cells were lysed by adding 200 l buffer containing ascorbic acid in supernatant-free wells for 30 min at room temperature. Finally, the 2Ј-5Ј adenylate contained in 50 l lysate was quantitated by using a radioimmunoassay. The results are representative of two independent experiments. There are several noteworthy considerations for the systems used in the study. Vero cells have been chosen because they are sensitive to various viruses causing a cytopathic effect in these cells. Transfected Vero cells expressing MxA allowed the demonstration that MxA, an IFN type I-induced molecule, is a powerful antiviral protein able to inhibit diverse groups of viruses (Pavlovic et al., 1992; Frese et al., 1995 Frese et al., , 1996 . Although the anti-CVB activity of IFN-␣ is known, the mechanism by which IFN-␣ inhibits CVB replication remains unclear. This is the first study focusing on the effects of MxA on CVB replication. The rationale for choosing CVB4E2 in our system was to examine the antiviral spectrum of MxA against a CVB4 strain, isolated from a patient with insulin-dependent diabetes mellitus (IDDM) (Gerling et al., 1991) . EV RNA with strong homology with CVB4 has been detected in the peripheral blood of patients with IDDM, and CVB4 infection was associated with activation of IFN-␣ synthesis in these patients (Chehadeh et al., 2000a) . Recently we brought evidence that a persistent infection of human pancreatic islets by CVB4, especially CVB4E2, is associated with interferon-␣ synthesis in ␤ cells (Chehadeh et al., 2000b) . Thus, it appears that CVB4 may play an important role in human pathology, especially IDDM, and that IFN-␣ is produced in the course of CVB4 infection; therefore an understanding of molecular basis of the interaction between that virus and IFN-␣ may provide insight into the mechanisms of the pathogenesis of CVB4-induced diseases.
Vero cells expressing MxA were protected from the cytopathic effect of CVB4, whereas cytopathic killing of control cultures was completed within 72 h.p.i. A very low level of infectious particles has been detected in the supernatant of CVB4-exposed MxA-expressing cells compared with control cells. The CVB replication at the molecular level was investigated. Immunofluorescence analysis revealed that no VA9 cell expressed VP1 capsid protein, whereas more than 80% of VN5 cells were positive for VP1 at 48 h.p.i. A drastic reduction of viral RNA synthesis was observed in CVB4-exposed VA9 cells compared with VN5 cells. Together these results show that CVB replication is strongly inhibited in MxA-expressing cells.
In VA9 cells the cytopathic effect of CVB4 was inhibited, whereas the cytopathic effect of HSV-1 was not different in VA9 and VN5 cells as expected since it has been already reported that MxA-expressing cells were not protected against the cytopathic effect of HSV1 (Landis et al., 1998) . In contrast with control cells, MxAexpressing cells were resistant to infection with VSV, a MxA-sensitive virus (Pavlovic et al., 1990) . These results show that the antiviral activity observed in VA9 cells against CVB4 was not due to antiviral physiological parameters of these cells and suggest that MxA exerts an intrinsic antiviral activity against CVB4.
Vero cells are devoid of type I IFN genes because of a chromosomal deletion in their genome (Diaz et al., 1988) ; thus the role of endogenous type I IFN-␣ in the anti-CVB activity of VA9 cells can be excluded. It has been reported that viruses can directly stimulate the synthesis of antiviral protein by cells independently of IFN-␣/␤ (Ronni et al., 1993; Baca et al., 1994) . VA9 and VN5 cells synthetized 2Ј-5Ј adenylate in response to IFN-␣, whereas the levels of 2Ј-5Ј adenylate were not higher in CVB-infected VA9 and VN5 cells than in mock-infected cells. Together these data argue against a major role of CVB4-induced 2Ј-5Ј adenylate in the anti-CVB effect observed in MxAexpressing cells.
CVB4 shares susceptibility to MxA with SFV, another positive-strand RNA virus (Landis et al., 1998) , and certain negative-strand RNA viruses: VSV, influenza virus, bunyaviruses, and Thogoto virus (Frese et al., 1995 (Frese et al., , 1996 Pavlovic et al., 1992; Staeheli and Pavlovic, 1991) .
The washing procedure of cells at 4°C before total RNA extraction eliminates the residual extracellular viral particles (Chehadeh et al., 2000b) . The detection of a low level of positive-strand RNA, probably related to the presence of CVB genome in the cytoplasm of the cells, associated with the lack of minus-strand RNA at 24 h.p.i. in CVB4-exposed VA9 cells by using RT-PCR suggests that the viral replication in MxA-expressing Vero cells was inhibited at an early step after the entry of viral genome into the cells.
The precise mechanism interfering with CVB replication remains to be elucidated; however, the abortion of viral infection at an early step of infection in the case of CVB is reminiscent of other reports. In the case of SFV, a positive-strand RNA virus, the antiviral effect of MxA is related to a block occurring early in the replicative cycle, and it has been demonstrated that viral components other than structural proteins are targets for MxA effect (Landis et al., 1998) . MxA protein selectively blocks the multiplication of negative-strand RNA viruses, VSV, members of the Bunyaviridae family, and Thogoto virus, by interacting with an early step of virus replication (Frese et al., 1995 (Frese et al., , 1996 . MxA protein selectively blocks the viral multiplication at the level of primary transcription for VSV (Schwemmle et al., 1995; Staeheli and Pavlovic, 1991) and blocks the transport of Thogoto virus nucleocapsids into the nucleus by binding to the nucleoprotein component, thereby preventing transcription of the viral genome (Kochs and Haller, 1999) . In contrast, MxA inhibits a step later than primary transcription for influenza virus (Pavlovic et al., 1992) .
These studies demonstrate that the antiviral activity of MxA against positive-strand RNA viruses is not restricted to SFV, one member of the Togaviridae family, but extends to CVB4, one member of the enterovirus group in the Picornaviridae family. There are differences between various genera of the Picornaviridae family which may explain why MxA is effective against CVB4 (enterovirus genera) and not other picornaviruses such as mengovirus and EMC (cardiovirus genera) (Landis et al., 1998) . Moreover, it has already been reported that negativestrand RNA viruses in the same family do not have the same susceptibility to MxA (Frese et al., 1995) . The current study shows that 2Ј-5Ј adenylate is not the sole system that can serve the antipicornavirus effects of IFN-␣. It has been suggested that the antiviral activity of MxA may be modulated by host factors (Frese et al., 1996) . It will be of interest to investigate the role of MxA in the infection of human host cells with CVB4 for a better FIG. 6. Agarose gel electrophoresis of amplicons specific to positivesense viral RNA (A) and negative-sense viral RNA (B) strands of enterovirus genome. HEp-2, VN5, and VA9 cells were infected with CVB4; m.o.i., 1 for 2 h 30 min at 37°C. Then the unadsorbed virus was removed by washing and the cultures were continued with fresh medium at 37°C. Strand-specific RT-PCR was carried out on total RNA taken from CVB4-infected and mock-infected cells CVB4 at 24 h.p.i. Lane 1 corresponds to 100-bp DNA molecular size ladder. Lanes 2 and 4 correspond to mock-infected VN5 and HEp-2 cells, respectively. Lanes 3 and 7 correspond to CVB4-infected VN5 and HEp-2 cells, respectively. Lanes 5 and 6 correspond to CVB4-infected VA9 cells (duplicates). Expression of ␤-actin mRNA was detected in all samples (C) . Representative experiments of two identically performed experiments are shown.
knowledge of mechanisms of anti-CVB defenses and pathogenesis of CVB4-induced diseases.
MATERIALS AND METHODS
Viruses
Coxsackie Virus B4 (CVB4) is the CVB4E2 strain (provided by Dr. Ji-Won Yoon, Calgary, Canada) grown in Hep-2 cells (Biowhittaker, Verviers, Belgium) in Eagle's minimum essential medium (MEM; GIBCO BRL, Paisley, Scotland) supplemented with 10% FCS and 1% L-glutamine. Supernatants were collected 3 days postinfection and then clarified at 1000 rpm for 10 min. Virus titers were determined by plaque-formation assay on HEp-2 cells and aliquots of virus preparations were then stored frozen at Ϫ80°C.
Vesicular stomatitis virus (kindly provided by P. Lebon, Paris, France) was grown in Vero cells (Biowhittaker) in Eagle's MEM (GIBCO BRL) supplemented with 10% FCS and 1% L-glutamine. Supernatants were collected 3 days postinfection and then clarified at 1000 rpm for 10 min. Virus titers were determined by plaque-formation assay on HEp-2 cells and aliquots of virus preparations were then stored frozen at Ϫ80°C.
Herpes simplex virus type-1 (laboratory strain) was cultivated in a Vero cell line (ATCC, Rockville, MD) in MEM supplemented with 5% FCS and 1% L-glutamine. After 48 h incubation at 37°C in 5% humidified CO 2 atmosphere, supernatants were collected and clarified at 1000 rpm for 10 min. HSV-1 titers were assayed by plaque formation on Vero cells and virus preparations were stored at Ϫ80°C.
Cell
Permanently transfected African green monkey kidney (Vero) cells constitutively expressing human MxA protein (clone VA9) and control cells expressing only the neomycin resistance gene (clone VN5) were grown in Dulbecco's modified Eagle's medium containing 10% fetal calf serum (GIBCO-BRL, Berlin, Germany), 1% of L-glutamine (Eurobio, Les Ulis, France) and 1% of nonessential amino acids (GIBCO-BRL, Paisley, Scotland) and 0.5 mg/ml neomycin-G418 (GIBCO-BRL) (Frese et al., 1996) .
Virus yield reduction assay
Confluent cell monolayers were infected as described. Culture supernatants were collected 24 h.p.i. and virus yields were determined on HEp-2 cells by TCID50 method 24 h.p.i. for VSV and 48 h for CVB4.
Immunofluorescence (IF)
Detection of MxA protein and enterovirus VP1. The cells were carefully washed with MEM. The cells were then trypsined, removed from the wells by pipetting, and washed twice before 2 ϫ 10 5 cells were cytocentrifuged onto clean glass slides. The slides were air-dried and fixed in a solution of 4% paraformaldehyde (PFA; Sigma) for 20 min at 4°C. The slides were washed twice in PBS and permeabilized with cold acetone/methanol (1 v/2 v) for 10 min at 20°C. After washing twice in PBS, the slides were incubated with 5% normal rabbit serum for 1 h at room temperature (RT) in a humidified chamber, washed twice in PBS, and incubated for 1 h at RT either with monoclonal anti-MxA at 1 g/spot. or with monoclonal anti-enterovirus VP1 (DAKO, Carpinteria, USA) at a dilution of 1:20. Following three washes in PBS, the slides were stained with 1:100 dilution of FITC-conjugated antimouse IgG antibodies (Sigma), counterstained with Evans blue (Sigma), and washed 3 times in PBS. Irrelevant mouse IgG antibodies (Coulter Immunotech) were used as controls. The slides were then mounted with permafluor (Coulter Immunotech), and positive cells were enumerated in a fluorescence microscope (Leitz Diaplan, Wetzlar, Germany).
Quantitation of MxA protein
Monolayers of both clones VA9 and VN5 have been incubated at 37°C in a 5% CO 2 humidified atmosphere for 24 h. Then, the culture medium was removed and the cells (0.5 ϫ 10 5 ) were washed twice with PBS prior to be lysed by 200 l buffer containing ascorbic acid (ACS 180, Bayer Diagnostics, Villeneuve D'Ascq, France) for 30 min at room temperature (Chieux et al., 1998) . Briefly, 200 l of lysate, standards, and controls were incubated simultaneously in plastic tubes with 100 l of Lite Reagent (N-hydroxysuccinimide-activated dimethyl-acridinium-ester-labeled detector antibody) and 200 l of solid phase (Paramagnetic-particles-conjugated antibody) (Bayer Diagnostics Corp., Alameda, CA). The tubes were then shaken by using a multi-tube vortexer (Model 4010, Bayer Diagnostics) for 3 min at room temperature. Then, these mixtures were incubated 30 min at 37°C. After incubation, the solid phase-bound immune complex was separated with a magnetized separator rack, Magic Rack (Bayer Diagnostics) for 3 min at room temperature. The separated pellets were then resuspended in 1 ml of distilled water using the multi-tube vortexer. The unbound antigen or antibody was discarded by decanting the rack. The separated pellets were then washed once more with 1 ml of distilled water as described above. Then, the separated pellets were resuspended in 100 l of distilled water. The relative luminescence units (RLUs) were counted by using a MLA-I luminometer (Bayer Diagnostics). The RLUs were converted in nanograms per milliliters by using a master curve. The background of MxA quantitation in various cell lines with negative MxA detection by IF that do not synthetize MxA represented 9 Ϯ 0.3 ng/ml MxA equivalent.
Quantitation of 2Ј-5Ј OAS
Cell preparation. Monolayers of VA9 and VN5 cells have been incubated in the absence or presence of CVB 4 , m.o.i. 0.1 for 2 h 30 min at 37°C in a 5% CO 2 humidified atmosphere. Then, the medium was removed and the cells were washed 5 times with culture medium. After that, the cultures were continued for 12 h in the same conditions. Finally, the culture medium was removed and the cells were washed twice with PBS prior to be lysed by 200 l buffer containing ascorbic acid (ACS 180, Bayer Diagnostics) for 30 min at room temperature. Since 2Ј-5Ј OAS is an IFN-␣/␤-induced antiviral protein, VA9 and VN5 cells were incubated in the presence of recombinant IFN-␣ 2b 100 IU/ml (Introna, Shering-Plough, Germany) for 12 h; then they were lysed and tested for their 2Ј-5Ј OAS concentration.
The intracellular concentration of 2Ј-5Ј OAS contained in 50 l lysate have been measured by radioimmunoassay with 125 I as the tracer and a second antibody used as the bound/free (B/F) separating agent (2-5A Kit I-AP75, Eiken Chemical Co. Ltd., Tokyo, Japan). Briefly, first the 2Ј-5Ј OAS in the sample is adsorbed and activated by using poly(I) poly(C) agarose; then 2Ј-5Ј adenylate is produced by using adenosine triphosphate (ATP) as the substrate. Next, a mixture of 125 I-labeled 2Ј-5Ј adenylate, anti-2Ј-5Ј adenylate serum, and second antibody is added. After 1 h incubation at 37°C, the mixture is centrifugally separated, and the B/F separation is performed by suction. Finally, the radioactivity of the precipitate is measured with a gamma counter (Diastar Packard, Netherland). The binding rate with respect to the initially added 125 I-labeled 2Ј-5Ј adenylate quantity is calculated, and the quantity of 2Ј-5Ј adenylate produced by the 2Ј-5Ј OAS in the sample is obtained from the standard curve which was made at the same time.
RT-PCR experiments
RNA extraction. Native RNA was extracted from cells by the acid guanidinium thiocyanate phenol chloroform extraction procedure using a commercial system (RNAgents Total RNA Isolation System, Promega, Madison, WI). Extracted RNA was then dissolved in 50 l of diethylpyrocarbonate (DEPC)-treated water (Aldrich, Saint Quentin Fallavier, France) and used in the RT-PCR assays.
Oligonucleotide primers. The sequences of the enterovirus-specific primers were selected in the 5Ј untranslated region of the viral genome, since this region is highly conserved among all enterovirus strains. Upstream primer, 5Ј-CAAGCACTTCTGTTTCCCCGG-3Ј, and downstream primer, 5Ј-ATTGTCACCATAAGCAGCCA-3Ј, generate a 435-bp fragment. These primers were synthesized by Eurogentec (Eurogentec Bel SA, Seraing, Belgium) and were previously described by Leparc et al. (1994) .
Beta-actin (␤-actin) primers were synthesized by Eurogentec; upstream primer: 5-ЈATCATGTTTGAGACCTC-CAA-3Ј; downstream primer: 5Ј-CATCTCTTGCTC-GAAGTCCA-3Ј. The amplified PCR fragment size is 318 bp.
RT-PCR reaction for plus-sense and minus-sense EV RNA strand detection. In the course of CVB replication, parental plus-sense RNA strand is transcribed into a minus-sense RNA strand which serves as a template for transcription into progeny plus-sense RNA strand. Downstream or upstream EV primer at 0.4 M was used as template in synthesis of complementary cDNA for 0.1 g plus-or minus-sense EV RNA strand, respectively, in a total volume of 20 l, using the enhanced avian RT-PCR kit (Sigma) according to the manufacturer's instructions. The transcription reaction was carried out at 50°C for 50 min and was stopped by heating the samples for 5 min at 95°C. The PCR reaction was carried out using 5 l of cDNA samples and 0.4 M of each primer, in a total volume of 50 l. For all specimens, ␤-actin mRNA was amplified using specific primers in a RT-PCR reaction. All PCR reactions were carried out using a Perkin-Elmer Applied GeneAmp PCR System 2400.
Detection of PCR products. The amplified RT-PCR products were analyzed on 2% agarose gel containing 0.5 g/ml of ethidium bromide (Sigma) and visualized using Gel Doc 2000system (Bio-Rad SA, Ivry-sur-seine, France). Image processing and analysis operations of DNA bands were performed using Quantity One software (Bio-Rad SA). A 100-bp DNA Ladder (GIBCO-BRL) was used as a molecular-weight marker.
In situ hybridization (ISH)
Enterovirus RNA-specific ISH was performed on cytospin preparations using nuclease-free polylysine-coated glass slides (Poly Labo, Paris, France) at 2 ϫ 10 5 cells/ spot. VA9, VN5, and HEp-2 cells were fixed in acetone for 20 min at RT and then immersed in Target retrieval solution (DAKO) at 95°C for 40 min (Chehadeh et al., 2000b) . Afterward, slides were washed twice in distilled water and treated for 5 min at RT with proteinase K (DAKO) diluted 1:5000 in 50 mM Tris-HCl buffer, pH 7.6 (Merck). Slides were washed and immersed in 0.3% H 2 O 2 in methanol at RT overnight. After washing, slides were hybridized in mRNA ISH solution (DAKO) containing 1 ng/l of biotinylated probe (5-(biotin)AAC-ACG-GAC-ACC-CAA-AGT-A-3) selected in the 5Ј untranslated region of the enteroviral genome. The probe was synthesized and labeled by Eurogentec. For each slide, 15 l of hybridization mixture was applied before nuclease-free Hybrislips (Poly Labo) were mounted, and hybridization was performed at 50°C for 90 min in a humidified chamber. Slides were then washed in Tris-buffered saline containing Tween-TBST (DAKO) for 20 min at RT. The hybridized probe was revealed by using Genpoint sys-tem (DAKO), consisting of an amplification of biotin signal by initial binding of peroxidase-conjugated streptavidin to the biotinylated probe followed by application of biotinyl-tyramide. The additional biotin is then used to capture more peroxidase-conjugated streptavidin. The signal is finally developed by adding the diaminobenzidine (DAB) dye to produce a dark brown precipitate at the site of hybridization. The sensitivity of ISH test was determined on HEp-2 cells infected with CVB4 (18% of HEp2 cells were labeled when infected at a m.o.i. of 1 PFU, and then hybridized 4 h after infection). To determine the specificity of signal, cells were subjected to RNase A (Boehringer Mannheim, Meylan, France) treatment at 100 g/ml for 2 h at 37°C before hybridization. RNase was heated at 100°C for 10 min and then allowed to cool to RT before use to abolish residual DNase activity.
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